Last week, we noted the Centers for Disease Control and Prevention report about a spike in dengue cases in Puerto Rico. It’s just more evidence of what we’ve been saying all along: global health R&D matters for Americans, both in terms of health and economics.
And, this weekend, a story in the Palm Beach (FL) Post helped fortify that and another argument we make: Cutting research is not a deficit-reduction strategy.
Dear Research Advocate,
By any measure, New York is one of the country’s top states for medical research and development: In FY11, the state attracted more than $2 billion across 4,606 awards from the National Institutes of Health. Only California and Massachusetts were better in either category.